In this quick clip from our BIO 2025 interview with Junevity Co-founder and CEO John Hoekman, PhD, Dr. Hoekman summarizes the potential of siRNA to fight diseases like diabetes and obesity.
Check out the full interview here!
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.